← All Telix Pharmaceuticals LTD filings

Telix Pharmaceuticals LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
TLX
Telix Pharmaceuticals LTD
20-F/A: Telix Pharmaceuticals Amends 20-F for Hyperlink Fixes
Telix Pharmaceuticals Limited filed an amendment to its 2025 annual report to correct exhibit hyperlinks and update executive certifications.
NASDAQ
TLX
Telix Pharmaceuticals LTD
20-F: Telix Pharmaceuticals Unveils Equity Incentive Plan Rules and Files 20-F
Telix Pharmaceuticals Limited announces the adoption of its Equity Incentive Plan Rules and files its 20-F form, outlining key details for employee incentives and company performance.